Evidence map›Paper›PMID 36163449›Full record

ArticleScientific reports2022

Computational and experimental elucidation of the boosted stability and antibacterial activity of ZIF-67 upon optimized encapsulation with polyoxometalates.

Aya M Mohamed, Walaa A Abbas, Ghada E Khedr, Wessam Abass, Nageh K Allam

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aya M MohamedEnergy Materials Laboratory (EML), School of Sciences and Engineering, The American University in Cairo, New Cairo, 11835, Egypt.
Walaa A AbbasEnergy Materials Laboratory (EML), School of Sciences and Engineering, The American University in Cairo, New Cairo, 11835, Egypt.
Ghada E KhedrEnergy Materials Laboratory (EML), School of Sciences and Engineering, The American University in Cairo, New Cairo, 11835, Egypt.
Wessam AbassSustainable Development Program, School of Sciences and Engineering, The American University in Cairo, New Cairo, 11835, Egypt.
Nageh K AllamEnergy Materials Laboratory (EML), School of Sciences and Engineering, The American University in Cairo, New Cairo, 11835, Egypt. nageh.allam@aucegypt.edu.
American University in Cairo · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Water microbial purification is one of the hottest topics that threats human morbidity and mortality. It is indispensable to purify water using antimicrobial agents combined with several technologies and systems. Herein, we introduce a class of nanosized metal organic framework; Zeolitic imidazolate framework (ZIF-67) cages encapsulated with polyoxometalates synthesized via facile one-step co-precipitation method. We employed two types of polyoxometalates bioactive agents; phosphotungstic acid (PTA) and phosphomolybdic acid (PMA) that act as novel antibacterial purification agents. Several characterization techniques were utilized to investigate the morphological, structural, chemical, and physical properties such as FESEM, EDS, FTIR, XRD, and N

Indexed as

Anti-Infective AgentsMetal-Organic FrameworksAnionsAnti-Bacterial AgentsEscherichia coliGram-Negative BacteriaGram-Positive BacteriaHumansPhosphotungstic AcidPolyelectrolytesPolyoxometalatesWaterAnionsAnti-Bacterial AgentsAnti-Infective AgentsMetal-Organic FrameworksPhosphotungstic AcidPolyelectrolytesPolyoxometalatesWater

Identifiers

PMID36163449
PMCPMC9512935
OpenAlexW4297238017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.